Itã¢â‚¬â„¢s Skin Smart Solution 365 Matt Finish Sun Gel Spf50+ Pa++++ Review
Offshoot membership is for researchers employed past other institutions who collaborate with IDM Members to the extent that some of their own staff and/or postgraduate students may piece of work within the IDM; for iii-twelvemonth terms, which are renewable.
BARRY III, Dr Clifton
PhD, Section Chief and Senior Investigator, Tuberculosis Research Department (TRS), National Plant of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health (NIH).
Areas of interest span the bones sciences of chemistry, biochemistry and microbiology, through to pharmacology and clinical medicine, in the areas of mycobacterial pathogenesis and TB drug discovery research.
Chocolate-brown, Prof Gordon
PhD, FRS, FMedSci, FRSB, FAAM, FRSE, RSSAf, Director MRC Middle for Medical Mycology at the University of Exeter and Manager of the AFGrica Unit at The University of Greatcoat Town (UCT). Honorary Professor at UCT.
His main enquiry interests are C-blazon lectin receptors and their role in homeostasis and amnesty, with a particular focus on antifungal immunity.
Grey, Prof Clive
Professor Emeritus of Immunology, Division of Immunology, Department of Pathology, Academy of Greatcoat Town; Professor of Immunology in Molecular Biological science and Man Genetics, Stellenbosch Academy, Cape Boondocks; Adjunct Professor, Department of Immunology, Duke Academy, North Carolina, United states of america; Secretary-Full general, Federation of African Immunology Societies; Vice-Chair, Education Committee of the IUIS; Director of the Immunopaedia Foundation.
His research interests revolve around investigating immune regulation and dysregulation in the context of HIV infection or exposure. He focuses on Immune ontogenesis in HIV exposed infants, placental investigations and pre-term nativity, and epithelial immunity in the foreskin. He has an active group within the IDM and is based at Stellenbosch University where he directs the Reproductive Immunology Research Consortium in Africa (RIRCA). He is the past Chair of Immunology at UCT and holder of several NIH and European-based grants.
GRAY, Prof Glenda
MBBCH, FCP (Paeds) SA. Executive Manager Perinatal HIV Research Unit of measurement, Wits Health Consortium, University of Witwatersrand; Associate Professor, Department of Paediatrics, Academy of Witwatersrand, South Africa; HVTN Managing director of International Programmes; HVTN Co-Principal Investigator; Chair of the standing committee on Health, ASSAF.
Her Research Unit is involved with clinical research, epidemiology and operational research, and is a treatment site for HIV infected adults and children. Her research interests include HIV vaccine enquiry, microbicide research and other biomedical and behavioural interventions, and she is an investigator in testing two HIV vaccine regimens in late stage clinical development. Her TB research includes examining new agents to forestall TB, TB prophylaxis and TB vaccine evaluation.
GROBUSCH, Prof Martin
Professor, Dr. Med. (Chiliad.D.), PhD, M.Sc. (Lond), DTM&H (Lond), FRCP (Lond). Specialist in Internal Medicine, Infectious Diseases, Tropical Medicine. Full Professor and Chair of Tropical Medicine and Travel Medicine and Head, Eye of Tropical Medicine and Travel Medicine, Amsterdam Medical Eye, University of Amsterdam in the netherlands.
He has been an author on over 150 manuscripts in the field of infectious diseases and has an extensive track record in infectious diseases research and do covering clinical, laboratory and epidemiological aspects.
LESLIE, Dr Al
Principal investigator Africa Health Enquiry Institute (AHRI), Durban, South Africa; Associate Professor, University of KwaZulu Natal, Durban, S Africa; Wellcome Trust senior Fellow, department of infection and immunity, Academy College London, UK.
He is an HIV and TB immunologist focused on studying the immune response to these pathogens in affected tissues, and how this relates to what can exist observed from the blood. The enquiry goal is to improve understanding of the immunopathology of TB and HIV, using this information to aid in developing novel therapeutic approaches and diagnostic biomarkers.
LEWINSOHN , Prof Dave
Dr., PhD, Professor and Vice Chair for Research, Department of Medicine, Director OHSU Center for Global Kid Health Enquiry, Department of Pediatrics.
His inquiry has centered on agreement the mechanisms past which the human immune system recognises the Mycobacterium tuberculosis (M.tb) infected cell. This inquiry has focused largely on CD8+ T cells, with a focus on both those antigens that are recognised, and the ways by which they are presented. His work has a strong translational component, asking if both classically and non-classically restricted T cells are associated with infection with Yard. tb, reflect immunological memory, and are enriched at the site of infection.
LEWINSOHN, Prof Deborah
Md, Professor, and Vice Chair for Inquiry, Partitioning Head Infectious disease, Wayne L. Tracy Professor of Communicable diseases, Section of Pediatrics, Assistant Managing director, OHSU Center for Global Child Wellness Research.
Her research focuses on agreement the part of the developing immune organization on the susceptibility of young children to tuberculosis (TB) and agreement the role of innate and adaptively acquired CD8+ T cells in host defense force to TB. The translational significance of this research is centred on informing the development of novel vaccines and diagnostics for childhood TB.
MOORE, A/Prof Penny
South African Research Chair in Viral Host Dynamics, Kinesthesia of Health Sciences, University of Witwatersrand and National Institute for Communicable Diseases.
Her current inquiry focuses on HIV broadly neutralising antibodies and their interplay with the evolving virus. Contempo studies published in PloS Pathogens, Nature and Nature Medicine have highlighted the role of viral escape in creating new epitopes and immunotypes, thereby driving the development of neutralisation breadth, with implications for HIV vaccine pattern.
NICOL, Prof Marker
School of Biomedical Sciences, Division of Infection and Immunity, University of Western Commonwealth of australia; Professor in Microbiology.
Inquiry interest in tuberculosis and in developing and testing indicate of care diagnostics suitable for the developing world.
REDD, Dr Andrew
PhD, Staff Scientist in International HIV and STD Section, National Found of Allergy and Infectious Diseases at the U.s. National Institutes of Health; Banana Professor of Medicine at Johns Hopkins University.
His research is focused on ameliorate understanding HIV manual and illness dynamics with a special concentration on HIV superinfection, latent HIV infection, and the role of the virus in HIV+ organ transplantation.
WILKINSON, A/Prof Katalin
Principal Research Scientist at The Francis Crick Plant London; Honorary Associate Professor, Division of Infection and Amnesty, University College London; Honorary Associate Professor, Department of Medicine, University of Cape Town.
Her research focuses on the immunology of HIV-associated tuberculosis (TB). More specifically, the reconstitution of the immune response during antiretroviral treatment, in order to identify correlates of protection (including allowed mechanisms that lead to reduced susceptibility to TB), and pathogenesis (such as the Tuberculosis-Associated Allowed Reconstitution Inflammatory Syndrome, TB-IRIS); the biosignature of the TB infection spectrum, from latent infection to active affliction; preventing TB infection in HIV infected people more effectively; and the pathogenesis of tuberculous meningitis and pericarditis.
Source: http://www.idm.uct.ac.za/Adjunct_Members